F FOSRENOL Trademark

Trademark Overview

On Thursday, July 3, 2003, a trademark application was filed for F FOSRENOL with the United States Patent and Trademark Office. The USPTO has given the F FOSRENOL trademark a serial number of 78270561. The federal status of this trademark filing is REGISTERED AND RENEWED as of Friday, July 24, 2015. This trademark is owned by Shire International Licensing BV. The F FOSRENOL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations and substances for the treatment of hyperphosphataemia, kidney disease and disorders, [ and osteoporosis ]
f fosrenol

General Information

Serial Number78270561
Word MarkF FOSRENOL
Filing DateThursday, July 3, 2003
Status800 - REGISTERED AND RENEWED
Status DateFriday, July 24, 2015
Registration Number2978995
Registration DateTuesday, July 26, 2005
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, May 18, 2004

Trademark Statements

Amendment to a Registration/Renewal CertificateIn the statement, column 1, line 9, "and osteoporosis" is deleted.
Description of the Colors ClaimedThe word FOSRENOL appears in blue and the fanciful letter "f" appears within a purple circle.
Goods and ServicesPharmaceutical preparations and substances for the treatment of hyperphosphataemia, kidney disease and disorders, [ and osteoporosis ]
Indication of Colors claimedThe color(s) blue and purple is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, July 17, 2003
Primary Code005
First Use Anywhere DateThursday, December 16, 2004
First Use In Commerce DateThursday, December 16, 2004

Trademark Owner History

Party NameTAKEDA PHARMACEUTICALS U.S.A., INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressLEXINGTON, MA 02421
Party NameShire International Licensing BV
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressAmsterdam NL-1076EE
NL
Party NameShire International Licensing BV
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNL-1076 EE Amsterdam
NL
Party NameShire International Licensing BV
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNL-1076 EE Amsterdam
NL

Trademark Events

Event DateEvent Description
Wednesday, March 1, 2023AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, July 2, 2020REVIEW OF CORRESPONDENCE COMPLETE - ADDRESS UPDATED
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, July 1, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, July 1, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Wednesday, July 1, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 1, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, July 1, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 24, 2015NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, July 24, 2015REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Friday, July 24, 2015REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, July 24, 2015CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, June 30, 2015TEAS SECTION 8 & 9 RECEIVED
Tuesday, August 30, 2011NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, August 30, 2011REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 29, 2011CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, July 18, 2011TEAS SECTION 8 & 15 RECEIVED
Thursday, May 21, 2009AMENDMENT UNDER SECTION 7 ¿ PROCESSED
Wednesday, May 20, 2009ASSIGNED TO PARALEGAL
Friday, April 24, 2009SEC 7 REQUEST FILED
Friday, April 24, 2009PAPER RECEIVED
Friday, September 1, 2006REVIEW OF CORRESPONDENCE COMPLETE
Wednesday, August 30, 2006REVIEW OF CORRESPONDENCE COMPLETE
Wednesday, August 30, 2006REVIEW OF CORRESPONDENCE COMPLETE
Monday, August 21, 2006PAPER RECEIVED
Tuesday, July 26, 2005REGISTERED-PRINCIPAL REGISTER
Thursday, May 5, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, April 29, 2005ASSIGNED TO LIE
Wednesday, April 27, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, April 12, 2005AMENDMENT FROM APPLICANT ENTERED
Wednesday, March 30, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, March 30, 2005PAPER RECEIVED
Monday, March 21, 2005SU - PRIORITY ACTION MAILED
Monday, March 21, 2005SU - PRIORITY ACTION WRITTEN
Wednesday, March 16, 2005ASSIGNED TO EXAMINER
Tuesday, February 8, 2005STATEMENT OF USE PROCESSING COMPLETE
Tuesday, February 8, 2005USE AMENDMENT FILED
Tuesday, February 8, 2005TEAS STATEMENT OF USE RECEIVED
Tuesday, August 10, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 18, 2004PUBLISHED FOR OPPOSITION
Wednesday, April 28, 2004NOTICE OF PUBLICATION
Tuesday, March 16, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, March 1, 2004CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 1, 2004PAPER RECEIVED
Friday, January 16, 2004NON-FINAL ACTION MAILED
Monday, August 25, 2003ASSIGNED TO EXAMINER

Related Keywords

fosrenol disease disorders osteoporosis kidney hyperphosphataemia preparations substances treatment pharmaceutical